<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiovascular</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиоваскулярная терапия и профилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Cardiovascular Therapy and Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1728-8800</issn><issn pub-type="epub">2619-0125</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1728-8800-2016-5-33-38</article-id><article-id custom-type="elpub" pub-id-type="custom">cardiovascular-485</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ИНФАРКТ МИОКАРДА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>MYOCARDIAL INFARCTION</subject></subj-group></article-categories><title-group><article-title>Резидуальный SYNTAX в прогнозировании отдаленных результатов эндоваскулярной реваскуляризации у больных инфарктом миокарда с элевацией сегмента ST при многососудистом поражении коронарного русла</article-title><trans-title-group xml:lang="en"><trans-title>SYNTAX residual in long-term outcomes prognosis of endovascular revascularization in myocardial infarction with ST elevation and multivessel disease</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тарасов</surname><given-names>Р. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Tarasov</surname><given-names>R. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д. м.н., зав. лабораторией реконструктивной хирургии мультифокального атеросклероза Тел.: + 7 (923) 526-04-46</p></bio><email xlink:type="simple">roman.tarasov@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ганюков</surname><given-names>В. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Ganyukov</surname><given-names>V. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д. м.н., зав. лабораторией интервенционных методов диагностики и лечения</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ваккосов</surname><given-names>К. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Vakkosov</surname><given-names>K. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>врач-ординатор</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Барбараш</surname><given-names>О. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Barbarash</surname><given-names>O. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>директор</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Барбараш</surname><given-names>Л. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Barbarash</surname><given-names>L. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>главный научный сотрудник</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ “Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний”. Кемерово, Россия</institution></aff><aff xml:lang="en"><institution>Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russia</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>20</day><month>10</month><year>2016</year></pub-date><volume>15</volume><issue>5</issue><fpage>33</fpage><lpage>38</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Тарасов Р.С., Ганюков В.И., Ваккосов К.М., Барбараш О.Л., Барбараш Л.С., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Тарасов Р.С., Ганюков В.И., Ваккосов К.М., Барбараш О.Л., Барбараш Л.С.</copyright-holder><copyright-holder xml:lang="en">Tarasov R.S., Ganyukov V.I., Vakkosov K.M., Barbarash O.L., Barbarash L.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://cardiovascular.elpub.ru/jour/article/view/485">https://cardiovascular.elpub.ru/jour/article/view/485</self-uri><abstract><sec><title>Цель</title><p>Цель. Изучить прогностическую значимость степени выраженности коронарного атеросклероза (резидуальный SYNTAX) после первичного чрескожного коронарного вмешательства (ЧКВ) у пациентов с инфарктом миокарда и подъемом сегмента ST (ИМ↑ST) при многососудистом поражении коронарного русла в отдаленном периоде наблюдения.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. В исследование включены 317 пациентов с ИМ↑ST, имеющих многососудистый коронарный атеросклероз, которым выполняли первичное ЧКВ. Исключались больные с гемодинамически значимым стенозом ствола левой коронарной артерии (≥50%), а также имеющие клинику отека легких или кардиогенного шока. Больные были разделены на две группы в зависимости от остаточной после первичного ЧКВ тяжести поражения коронарного русла по шкале SYNTAX: ≤8 баллов (n=243) и ≥9 баллов (n=74). Средний период наблюдения составил 36,7±24,3 мес. Учитывались неблагоприятные кардиоваскулярные события: смерть, инфаркт миокарда (ИМ), повторная реваскуляризация целевого сосуда и нецелевого сосуда, также регистрировали случаи тромбоза стента. </p></sec><sec><title>Результаты</title><p>Результаты. Пациенты с выраженным после первичного ЧКВ резидуальным коронарным атеросклерозом, в сравнении с больными с умеренным резидуальным SYNTAX характеризовались более старшим возрастом — 63,1±10,6 лет vs 58,8±9,9 лет, соответственно (р=0,001), преобладали пациенты женского пола — 55,9% vs 31,3%, соответственно (р=0,03), более значительная доля больных с мультифокальным атеросклерозом — 37,8% vs 24,3%, соответственно (р=0,03), доминирование трехсосудистого поражения коронарного русла — 83,8% vs 49% (0,0001) и более редкая реализация стратегии многососудистого стентирования в рамках первичного ЧКВ — 9,5% vs 32,9%, соответственно (р=0,0001). В отдаленном периоде наблюдения (36,7±24,3 мес.) среди пациентов группы SYNTAX ≥9 баллов в сравнении с группой SYNTAX ≤8 баллов отмечен менее благоприятный прогноз, что выражалось в большей частоте смерти от всех причин — 16,2% vs 5,3%, соответственно (р=0,005), отношении шансов (ОШ) 3,4 (1,5-7,9; 95% ДИ), (р=0,004), повторного ИМ — 16,2% vs 6,6%, соответственно (р=0,02), ОШ 2,7 (1,2-6,1; 95% ДИ), (р=0,01), повторной реваскуляризации нецелевых сосудов — 18,9% vs 8,2%, соответственно (р=0,02), ОШ 2,6 (1,2-5,5; 95% ДИ), (р=0,01).</p></sec><sec><title> </title><p> </p></sec><sec><title>Заключение</title><p>Заключение. Показатель резидуальной тяжести поражения коронарного русла по шкале SYNTAX ≥9 баллов продемонстрировал высокую прогностическую значимость, значительно увеличивая вероятность большинства неблагоприятных кардиоваскулярных событий. Таким образом, пациенты с ИМ↑ST, имеющие многососудистое поражение коронарного русла со значением резидуального SYNTAX ≥9 баллов после первичного ЧКВ, требуют выполнения полной реваскуляризации миокарда, что может быть реализовано путем более широкого использования стратегии многососудистого стентирования в рамках первичного ЧКВ, или поэтапного ЧКВ в оптимальный интервал времени (госпитальный период).</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To study prognostic significance of coronary atherosclerosisseverity (residual SYNTAX) after primary percutaneous intervention (PCI) in myocardial infarction patients with STE (STEMI) and multivessel coronary lesion, in long term period.</p></sec><sec><title>Material and methods</title><p>Material and methods. Totally, 317 STEMI patients included, having multivessel coronary atherosclerosis, underwent primary PCI. Patients were excluded if having hemodynamically significant left coronary stem stenosis (≥50%), and with signs of cardiogenic shock or pulmonary edema. Patients were selected to 2 groups depending on the residual lesion after primary PCI, by SYNTAX: ≤8 points (n=243) and ≥9 points (n=74). Mean follow-up was 36,7±24,3 months. The adverse cardiovascular events were taken: death, myocardial infarction (MI), second revascularization of the target and non-target vessel, as the cases of stent thrombosis.</p></sec><sec><title>Results</title><p>Results. Patients with the significant after primary PCI residual coronary atherosclerosis, comparing to those with mild residual SYNTAX were older — 63,1±10,6 y. vs 58,8±9,9 y., resp. (р=0,001), females predominated — 55,9% vs 31,3%, resp. (р=0,03), more significant was part of multivessel disease — 37,8% vs 24,3%, resp. (р=0,03), three vessel lesion predominated — 83,8% vs 49% (0,0001) and less common performing of the strategy of primary PCI — 9,5% vs 32,9%, resp. (р=0,0001). In long term follow-up (36,7±24,3 months.) among those with SYNTAX ≥9 comparing to those SYNTAX ≤8 pts. there was worse prognosis, that represented as higher mortality from all causes — 16,2% vs 5,3%, resp. (р=0,005), odds ratio (OR) 3,4 (1,5-7,9; 95% CI), (р=0,004); second MI — 16,2% vs 6,6%, resp. (р=0,02), OR 2,7 (1,2-6,1; 95% CI), (р=0,01), second non-target revascularization — 18,9% vs 8,2%, resp. (р=0,02), OR 2,6 (1,2-5,5; 95% CI), (р=0,01).</p></sec><sec><title> </title><p> </p></sec><sec><title>Conclusion</title><p>Conclusion. Value of residual coronary lesion by SYNTAX ≥9 showed higher prognostic significance, seriously raising the probability of most adverse cardiovascular events. Therefore, STEMI patients with multivessel disease and residual SYNTAX ≥9 pts. after primary PCI should undergo complete myocardial revascularization that can be done via broader application of the strategy of multivascular stenting under primary PCI, and staged PCI within optimal time frame (in-hospital period).</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>инфаркт миокарда с подъемом сегмента ST</kwd><kwd>первичное ЧКВ</kwd><kwd>многососудистое поражение</kwd><kwd>резидуальный SYNTAX.</kwd></kwd-group><kwd-group xml:lang="en"><kwd>ST-elevation myocardial infarction</kwd><kwd>primary PCI</kwd><kwd>multivessel lesion</kwd><kwd>residual SYNTAX</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010; 31(20): 2501- 55.</mixed-citation><mixed-citation xml:lang="en">Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010; 31(20): 2501- 55.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Widimsky P, Holmes Jr, David R. How to treat patients with ST-elevation acute myocardial infarction and multi-vessel disease? Eur Heart J 2010; Advance Access published November 30, 2010. European Heart Journal doi:10.1093/eurheartj/ehq410.</mixed-citation><mixed-citation xml:lang="en">Widimsky P, Holmes Jr, David R. How to treat patients with ST-elevation acute myocardial infarction and multi-vessel disease? Eur Heart J 2010; Advance Access published November 30, 2010. European Heart Journal doi:10.1093/eurheartj/ehq410.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Windecker S, Kolh Ph, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization. Eur. Heart J 2014; 278: 25-7.</mixed-citation><mixed-citation xml:lang="en">Windecker S, Kolh Ph, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization. Eur. Heart J 2014; 278: 25-7.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Wald DS, Joan K, et al. PRAMI Investigators Randomized Trial of Preventive Angioplasty in Myocardial Infarction. N Engl J Med 2013; 369: 1115-23.</mixed-citation><mixed-citation xml:lang="en">Wald DS, Joan K, et al. PRAMI Investigators Randomized Trial of Preventive Angioplasty in Myocardial Infarction. N Engl J Med 2013; 369: 1115-23.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Addala S, Grines CL, Dixon SR, et al. Predicting mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score). Am J Cardiol 2004; 93: 629-32.</mixed-citation><mixed-citation xml:lang="en">Addala S, Grines CL, Dixon SR, et al. Predicting mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score). Am J Cardiol 2004; 93: 629-32.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Halkin A, Singh M, Nikolsky E, et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. JAСC 2005; 45: 1397-405.</mixed-citation><mixed-citation xml:lang="en">Halkin A, Singh M, Nikolsky E, et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. JAСC 2005; 45: 1397-405.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 2000; 102: 2031-7.</mixed-citation><mixed-citation xml:lang="en">Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 2000; 102: 2031-7.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Eagle KA, Lim MJ, Dabbous OH. GRACE Investigators, et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 2004; 291: 2727-33.</mixed-citation><mixed-citation xml:lang="en">Eagle KA, Lim MJ, Dabbous OH. GRACE Investigators, et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 2004; 291: 2727-33.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">De Luca G, Suryapranata H, van’t Hof AW, et al. Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge. Circulation 2004; 109: 2737-43.</mixed-citation><mixed-citation xml:lang="en">De Luca G, Suryapranata H, van’t Hof AW, et al. Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge. Circulation 2004; 109: 2737-43.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease. New Engl J Med 2009; 360(10): 961-72.</mixed-citation><mixed-citation xml:lang="en">Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease. New Engl J Med 2009; 360(10): 961-72.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Serruys PW, Onuma Y, Garg S, et al. Assessment of the SYNTAX score in the SYNTAX study. EuroIntervention 2009; 5: 50-6.</mixed-citation><mixed-citation xml:lang="en">Serruys PW, Onuma Y, Garg S, et al. Assessment of the SYNTAX score in the SYNTAX study. EuroIntervention 2009; 5: 50-6.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Garg S, Sarno G, Serruys РW, et al. Prediction of 1-Year Clinical Outcomes Using the SYNTAX Score in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. JACC 2011; 4(1): 66-75.</mixed-citation><mixed-citation xml:lang="en">Garg S, Sarno G, Serruys РW, et al. Prediction of 1-Year Clinical Outcomes Using the SYNTAX Score in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. JACC 2011; 4(1): 66-75.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Yang CH, Hsieh MJ, Chen CC, et al. SYNTAX score: an independent predictor of long- term cardiac mortality in patients with acute ST-elevation myocardial infarction. Coron Artery Di 2012; 23(7): 445-9.</mixed-citation><mixed-citation xml:lang="en">Yang CH, Hsieh MJ, Chen CC, et al. SYNTAX score: an independent predictor of long- term cardiac mortality in patients with acute ST-elevation myocardial infarction. Coron Artery Di 2012; 23(7): 445-9.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Tarasov RS, Ganyukov VI, Shushpannikov PA, et al. SYNTAX score estimates of coronary stenosis severity and outcomes of various revascularization strategies in patients with ST segment elevation myocardial infarction and multi-vessel coronary pathology. Russ J Cardiol 2013; 2(100): 31-7. Russian (Тарасов Р. С., Ганюков В. И., Шушпанников П. А. и др. Исходы различных стратегий реваскуляризации у больных инфарктом миокарда с элевацией сегмента ST при многососудистом поражении в зависимости от тяжести стенозирования коронарного русла по шкале “SYNTAX”. Российский кардиологический журнал 2013; 2(100): 31-7).</mixed-citation><mixed-citation xml:lang="en">Tarasov RS, Ganyukov VI, Shushpannikov PA, et al. SYNTAX score estimates of coronary stenosis severity and outcomes of various revascularization strategies in patients with ST segment elevation myocardial infarction and multi-vessel coronary pathology. Russ J Cardiol 2013; 2(100): 31-7. Russian (Тарасов Р. С., Ганюков В. И., Шушпанников П. А. и др. Исходы различных стратегий реваскуляризации у больных инфарктом миокарда с элевацией сегмента ST при многососудистом поражении в зависимости от тяжести стенозирования коронарного русла по шкале “SYNTAX”. Российский кардиологический журнал 2013; 2(100): 31-7).</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Farooq V, Serruys PW, Bourantas CV, et al. Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX score. Circulation 2013; 128(2): 141-51.</mixed-citation><mixed-citation xml:lang="en">Farooq V, Serruys PW, Bourantas CV, et al. Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX score. Circulation 2013; 128(2): 141-51.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Melina G, Angeloni E, Refice S, et al. Prognostic Value of the Residual SYNTAX Score to Quantify Untreated Coronary Artery Disease After Coronary Artery Bypass Grafting. Circulation 2013; 128: A17110.</mixed-citation><mixed-citation xml:lang="en">Melina G, Angeloni E, Refice S, et al. Prognostic Value of the Residual SYNTAX Score to Quantify Untreated Coronary Artery Disease After Coronary Artery Bypass Grafting. Circulation 2013; 128: A17110.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Généreux SP, Palmerini T, Caixeta A, et al. Quantification and Impact of Untreated Coronary Artery Disease After Percutaneous Coronary Intervention The Residual SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery). JACC 2012; 59: 2165-74.</mixed-citation><mixed-citation xml:lang="en">Généreux SP, Palmerini T, Caixeta A, et al. Quantification and Impact of Untreated Coronary Artery Disease After Percutaneous Coronary Intervention The Residual SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery). JACC 2012; 59: 2165-74.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
